Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia
- 1 April 2003
- Vol. 61 (4) , 791-796
- https://doi.org/10.1016/s0090-4295(02)02548-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 yearsUrology, 1999
- Natural history of prostatism: Impact of urinary symptoms on quality of life in 2115 randomly selected community menUrology, 1994
- Androgen Metabolism in Men Receiving Finasteride before ProstatectomyJournal of Urology, 1993
- Finasteride (MK‐906) in the treatment of benign prostatic hyperplasiaThe Prostate, 1993
- The Effect of Finasteride in Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1992
- Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasiaJournal of Clinical Endocrinology & Metabolism, 1992
- Treatment of Benign Prostatic Hyperplasia by Androgen Deprivation: Effects on Prostate Size and Urodynamic ParametersJournal of Urology, 1989
- The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic HyperplasiaNew England Journal of Medicine, 1987
- Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male PseudohermaphroditismScience, 1974
- Familial Incomplete Male Pseudohermaphroditism, Type 2New England Journal of Medicine, 1974